Risk of declines in the value of partners and investees
First written in FY2016. 21 of 33 entries say "Materialised", first in FY2017-Q1. Latest entry: FY2026.
Rohto Pharmaceutical moved to the "Worse" side of this theme in 2016, 5 years before the typical company in this theme (2021).
The whole theme swung hardest in 2019: 43 of 89 companies on the "Worse" side.
30 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「During the consolidated fiscal year, the company recognized impairment losses of ¥1,229 million on securities, all of which were shares classified as other securities.」
Impairment losses on investment securities and shares of affiliated companies totaled ¥1,244 million, down from the previous fiscal year's total of ¥2,074 million. However, losses due to declines in value continued to be recognized. - 2026-05-13MitigatedRevision to earnings forecast
「Impairment loss on investment securities 2,048 1,229」
The impairment loss on investment securities declined from ¥2,048 million in the previous fiscal year to ¥1,229 million, although an impairment loss was still recorded. - FY2026-H1WorsenedAnnual report
「Impairment loss on investment securities 1,067」
The impairment loss on investment securities increased from ¥785 million in the same period of the previous year to ¥1,067 million, and losses recognized due to declines in the value of investments and securities held increased. - FY2025-H1WorsenedAnnual report
「Impairment loss on investment securities 785」
An impairment loss on investment securities of ¥785 million was recorded for the interim consolidated accounting period, up from ¥134 million in the same period of the previous year. Losses recognized due to declines in the value of investments and securities held increased. - FY2024WorsenedAnnual report
「During the consolidated fiscal year, the company recognized impairment losses of ¥798 million on securities, comprising ¥731 million on shares classified as other securities and ¥67 million on shares in affiliates.」
Impairment losses from declines in the value of investments and securities held amounted to ¥798 million, up from ¥300 million in the previous fiscal year. - FY2024-Q3MaterialisedAnnual report
「Impairment loss on investment securities 676」
During the cumulative third quarter, a loss on valuation of investment securities of ¥676 million was recorded, with the risk of declines in the value of partners and investees materializing as a loss. - FY2024-Q2MaterialisedAnnual report
「Loss on valuation of investment securities 134」
During the cumulative second quarter under review, a loss on valuation of investment securities of ¥134 million was recorded, with the risk of declines in the value of partners and investees materializing as a loss. - FY2024-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」
It is stated that there has been no material change regarding the risk of declines in the value of partners and investees. - FY2023MitigatedAnnual report
「During the consolidated fiscal year, the company recognized impairment losses of ¥300 million on securities, comprising ¥103 million on shares classified as other securities and ¥197 million on shares in affiliates.」
Impairment losses on investment securities and shares of affiliates totaled ¥300 million, down from ¥874 million in the previous fiscal year. Losses resulting from declines in the value of investees remain, but the amount has decreased. - FY2023-Q3MitigatedAnnual report
「Loss on valuation of investment securities - Loss on valuation of shares of affiliates -」
No losses on valuation of investment securities or shares of affiliates were recorded during the cumulative third quarter, representing an improvement from the valuation losses recorded in the same period of the previous year. - FY2023-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」
It is stated that there has been no material change regarding the risk of declines in the value of partners and investees. - FY2022-Q3WorsenedAnnual report
「Impairment loss on investment securities 557 Impairment loss on shares in affiliates 88」
During the cumulative third quarter, a loss on valuation of investment securities of ¥557 million and a loss on valuation of shares of affiliates of ¥88 million were recorded. Valuation losses increased from ¥109 million and ¥72 million, respectively, in the cumulative second quarter, indicating an expansion in losses recognized due to the risk of declines in value. - FY2022-Q2MaterialisedAnnual report
「Impairment loss on investment securities 109 Impairment loss on shares in affiliates 72」
During the cumulative second quarter, a loss on valuation of investment securities of ¥109 million and a loss on valuation of shares of affiliates of ¥72 million were recorded, with declines in the value of investees and held securities materializing as losses. - FY2022-Q1MaterialisedAnnual report
「Impairment loss on investment securities 109」
In the first quarter, a loss on valuation of investment securities of ¥109 million was recorded, with the risk of declines in the value of investees and held securities continuing to materialize as a loss. - FY2021WorsenedAnnual report
「During the consolidated fiscal year, the company recognized impairment losses of ¥1,986 million on securities, comprising ¥1,484 million on shares classified as other securities and ¥502 million on shares in affiliates.」
Declines in the value of investees and held securities materialized as impairment losses of ¥1,986 million, up from ¥1,548 million in the previous fiscal year. - FY2021-Q3MaterialisedAnnual report
「Impairment loss on investment securities 1,411 Impairment loss on shares in affiliates 247」
During the cumulative third quarter, a loss on valuation of investment securities of ¥1,411 million and a loss on valuation of shares of affiliates of ¥247 million were recorded, with the risk of declines in the value of investees and held securities continuing to materialize as a loss. - FY2021-Q2MaterialisedAnnual report
「Impairment loss on investment securities 1,331 Impairment loss on shares in affiliates 229」
During the cumulative second quarter, a loss on valuation of investment securities of ¥1,331 million and a loss on valuation of shares of affiliates of ¥229 million were recorded, with declines in the value of investees and held securities materializing as losses. - FY2021-Q1MaterialisedAnnual report
「Impairment loss on investment securities 987」
A loss on valuation of investment securities of ¥987 million was recorded, with the risk of declines in the value of investees and held securities continuing to materialize as a loss. - FY2020MaterialisedAnnual report
「During the consolidated fiscal year under review, impairment losses of ¥1,548 million were recognized on securities, comprising ¥1,263 million on shares classified as other securities and ¥285 million on shares of affiliates.」
The risk of declines in the value of investees and held securities continued to materialize as impairment losses of ¥1,263 million on other securities and ¥285 million on shares of affiliates. - FY2020-Q3MaterialisedAnnual report
「Loss on valuation of investment securities 377 Loss on valuation of shares of affiliates 144」
During the cumulative third quarter, a loss on valuation of investment securities of ¥377 million and a loss on valuation of shares of affiliates of ¥144 million were recorded, with declines in the value of investees and held securities materializing as losses. - FY2020-Q2MaterialisedAnnual report
「Loss on valuation of investment securities 298 Loss on valuation of shares of affiliates 143」
Loss on valuation of investment securities of ¥298 million and loss on valuation of shares of affiliates of ¥143 million were recorded, with declines in the value of investees and held securities materializing as losses. - FY2020-Q1MaterialisedAnnual report
「Impairment losses on investment securities ¥748 million Impairment losses on shares of affiliated companies ¥92 million」
Loss on valuation of investment securities of ¥748 million and loss on valuation of shares of affiliates of ¥92 million were recorded, with declines in the value of investees and held securities materializing as losses. - FY2019-Q3MaterialisedAnnual report
「Impairment losses on investment securities ¥170 million Impairment losses on shares of affiliated companies ¥299 million」
Loss on valuation of investment securities of ¥170 million and loss on valuation of shares of affiliates of ¥299 million were recorded, with declines in the value of investees and held securities continuing to materialize as losses. - FY2019-Q2MaterialisedAnnual report
「Loss on valuation of investment securities 2 121 Loss on valuation of shares of affiliates 0 －」
During the cumulative second quarter, a loss on valuation of investment securities of ¥121 million was recorded, with the risk of declines in the value of investees and held securities continuing to materialize as a loss. - FY2019-Q1MaterialisedAnnual report
「Loss on valuation of investment securities 121 Loss on valuation of shares of affiliates －」
In the first quarter under review, a loss on valuation of investment securities of ¥121 million was recorded, with declines in the value of investees and held securities continuing to materialize as losses. - FY2018-Q3MaterialisedAnnual report
「Loss on valuation of investment securities 385 2 Loss on valuation of shares of affiliates 6 0」
During the cumulative third quarter, a loss on valuation of investment securities of ¥2 million and a loss on valuation of shares of affiliates of ¥0 million were recorded, with declines in the value of investees and held securities continuing to materialize as losses. - FY2018-Q2MaterialisedAnnual report
「Loss on valuation of investment securities 329 2 Loss on valuation of shares of affiliates 6 0」
During the cumulative second quarter under review, a loss on valuation of investment securities of ¥2 million and a loss on valuation of shares of affiliates of ¥0 million were recorded, with declines in the value of investees and held securities continuing to materialize as losses. - FY2018-Q1MaterialisedAnnual report
「Loss on valuation of investment securities 217 2 Loss on valuation of shares of affiliates 6 0」
In the first quarter under review, a loss on valuation of investment securities of ¥2 million and a loss on valuation of shares of affiliates of ¥0 million were recorded, with declines in the value of investees and held securities continuing to materialize as losses. - FY2017MaterialisedAnnual report
「During the consolidated fiscal year under review, impairment losses of ¥319 million were recognized on listed shares classified as other securities and ¥138 million on unlisted shares.」
Declines in the value of investees and held securities have continued to materialize as impairment losses of ¥319 million on listed shares and ¥138 million on unlisted shares. - FY2017-Q3MaterialisedAnnual report
「Loss on valuation of investment securities 385 Loss on valuation of shares of affiliates 6 Provision for allowance for doubtful accounts 440 Provision for allowance for doubtful accounts for affiliates 3」
Loss on valuation of investment securities of ¥385 million and loss on valuation of shares of affiliates of ¥6 million were recorded, with declines in the value of investees and held securities continuing to materialize as losses. - FY2017-Q2MaterialisedAnnual report
「Loss on valuation of investment securities 329 Loss on valuation of shares of affiliates 6」
During the cumulative second quarter, a loss on valuation of investment securities of ¥329 million and a loss on valuation of shares of affiliates of ¥6 million were recorded, with declines in the value of investees and held securities materializing as losses. - FY2017-Q1MaterialisedAnnual report
「Loss on valuation of investment securities 217 Loss on valuation of shares of affiliates 6」
Loss on valuation of investment securities of ¥217 million and loss on valuation of shares of affiliates of ¥6 million were recorded, with declines in the value of investees and held securities materializing as losses. - FY2016First statedAnnual report
「Accordingly, we engage in investment activities such as establishing new companies in partnership with other companies and investing in existing companies, and may continue to do so. If the enterprise value of an investee or the market value of its shares or other securities declines, our operating results and financial position may be affected.」
The company establishes new companies and invests in other companies to expand existing businesses and develop new businesses, identifying declines in the enterprise and market value of investees as risks.